Denti, Michela Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 9.375
AS - Asia 3.330
EU - Europa 2.822
SA - Sud America 511
Continente sconosciuto - Info sul continente non disponibili 259
AF - Africa 63
OC - Oceania 11
Totale 16.371
Nazione #
US - Stati Uniti d'America 9.213
SG - Singapore 1.424
CN - Cina 674
VN - Vietnam 618
RU - Federazione Russa 437
IT - Italia 432
BR - Brasile 413
SE - Svezia 361
UA - Ucraina 324
FI - Finlandia 306
GB - Regno Unito 225
DE - Germania 185
FR - Francia 159
LV - Lettonia 128
KR - Corea 127
CA - Canada 98
IN - India 86
BD - Bangladesh 69
NL - Olanda 65
BG - Bulgaria 50
HK - Hong Kong 41
ES - Italia 39
ID - Indonesia 35
IQ - Iraq 32
TR - Turchia 32
JO - Giordania 30
AR - Argentina 26
ZA - Sudafrica 26
PL - Polonia 25
MX - Messico 24
JP - Giappone 23
VE - Venezuela 20
IR - Iran 19
AT - Austria 17
CO - Colombia 17
MY - Malesia 17
PK - Pakistan 16
EC - Ecuador 12
JM - Giamaica 11
LT - Lituania 11
IE - Irlanda 10
AU - Australia 9
PH - Filippine 9
NP - Nepal 8
UZ - Uzbekistan 8
BE - Belgio 7
CH - Svizzera 7
CL - Cile 7
EG - Egitto 7
KE - Kenya 7
SA - Arabia Saudita 7
TH - Thailandia 7
UY - Uruguay 7
CR - Costa Rica 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
IL - Israele 5
KZ - Kazakistan 5
RO - Romania 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
GR - Grecia 4
GT - Guatemala 4
HR - Croazia 4
OM - Oman 4
PY - Paraguay 4
TN - Tunisia 4
AL - Albania 3
DO - Repubblica Dominicana 3
HN - Honduras 3
LK - Sri Lanka 3
MM - Myanmar 3
NI - Nicaragua 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
TW - Taiwan 3
BO - Bolivia 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
NO - Norvegia 2
PR - Porto Rico 2
QA - Qatar 2
SN - Senegal 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
Totale 16.103
Città #
Singapore 885
Ashburn 875
Chandler 832
Jacksonville 678
Fairfield 649
San Jose 553
Dallas 359
Columbus 330
Woodbridge 322
Santa Clara 281
Wilmington 277
Seattle 267
Houston 266
Ann Arbor 240
San Mateo 235
Cambridge 213
Princeton 207
Moscow 195
Beijing 185
Helsinki 176
Council Bluffs 175
Ho Chi Minh City 167
New York 143
The Dalles 140
Hanoi 139
Riga 128
Seoul 123
Los Angeles 122
Phoenix 115
Lauterbourg 110
Trento 92
Dearborn 80
Boardman 74
Buffalo 64
Hefei 61
São Paulo 52
Munich 49
San Diego 48
Sofia 46
Milan 45
Orem 44
North Bergen 43
London 39
Bremen 36
Chicago 35
Fremont 34
Hong Kong 33
Da Nang 31
Dong Ket 31
Lawrence 29
Delft 28
Denver 28
Jakarta 26
Ottawa 26
Rome 26
Haiphong 24
Chennai 23
Frankfurt am Main 23
Toronto 22
Warsaw 22
Brooklyn 21
Como 21
Lappeenranta 20
Johannesburg 19
Norwalk 19
Tokyo 19
Stockholm 18
Atlanta 17
Poplar 17
Redondo Beach 17
San Paolo di Civitate 17
Montreal 16
Guangzhou 15
Manchester 15
Nuremberg 15
Tehran 15
Belo Horizonte 14
Biên Hòa 14
Izmir 14
Verona 13
Amsterdam 12
Des Moines 12
Mumbai 12
Washington 12
Boston 11
Kilburn 11
New Delhi 11
Shanghai 11
Badajoz 10
Hillsboro 10
Hải Dương 10
Ipoh 10
Rio de Janeiro 10
Salt Lake City 10
Vienna 10
Ankara 9
Calgary 9
Charlotte 9
Falkenstein 9
Kunming 9
Totale 11.144
Nome #
The short-term impact of probiotic consumption on the oral cavity microbiome 287
The miR-15/107 Family of microRNA Genes Regulates CDK5R1/p35 with Implications for Alzheimer’s Disease Pathogenesis 232
Enhanced microbial diversity in the saliva microbiome induced by short-term probiotic intake revealed by 16S rRNA sequencing on the IonTorrent PGM platform 224
A Cross-Platform Comparison of Affymetrix and Agilent Microarrays Reveals Discordant miRNA Expression in Lung Tumors of c-Raf Transgenic Mice 219
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 215
A new splicing isoform of Cacna2d4 mimicking the effects of c.2451insC mutation in the retina: Novel molecular and electrophysiological insights 211
RNA intereference mediated therapy for neurodegenerative diseases 205
Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations 205
Statistical analysis of a Bayesian classifier based on the expression of miRNAs 204
Reduced miR-659-3p levels correlate with progranulin increase in hypoxic conditions: Implications for frontotemporal dementia 204
An electroporation protocol for efficient DNA transfection in PC12 cells 199
DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells 199
Selection of reference genes is critical for miRNA expression analysis in human cardiac tissue. A focus on atrial fibrillation 194
Plasma microRNA profiling distinguishes patients with frontotemporal dementia from healthy subjects 185
microRNAs make the call in cancer personalized medicine 184
microRNA-375 expression distinguishes neuroendocrine from non-neuroendocrine lung tumours in FFPE samples 183
Oligonucleotide therapy 176
Comparison of different methods to extract RNA from cardiac tissue for miRNA profiling by qRT-PCR 176
A network in FrontoTemporal Dementia - an RNA perspective 174
Splicing-correcting therapeutic approaches for retinal dystrophies: where endogenous gene regulation and specificity matter. 173
Delivery is key: Lessons learnt from developing splice-switching antisense therapies 172
AAV-Mediated Allele-Specific RNA Interference of a Common Dominant Rhodopsin Mutation Causing Retinitis Pigmentosa 171
A novel RNA-binding protein from Triturus carnifex identified by RNA-ligand screening with the newt hammerhead ribozyme 171
Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases 169
Antisense RNA-mediated exon skipping in gene therapy 169
New Platform for the Direct Profiling of microRNAs in Biofluids 167
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 164
AAV-mediated Allele-specific RNA interference of a common dominant Rhodopsin mutation causing Retinitis Pigmentosa 161
A chimeric adeno-associated virus/antisense-U1small nuclear RNA effectively rescues dystrophin synthesis and muscle function by local treatment of mdx mice 160
MiRNA-QC-and-Diagnosis: An R package for diagnosis based on MiRNA expression 160
DNMT3A epigenetically regulates key microRNAs involved in epithelial-to-mesenchymal transition in prostate cancer 160
MicroRNAs in epithelial ovarian cancer 159
miR-205 expression levels in non-small cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas. 159
A new vector, based on the polII promoter of U1 snRNA gene, for the expression of siRNAs in mammalian cells 158
Identification of new p53 target microRNAs by bioinformatics and functional analysis 157
A loxP-containing pol II promoter for RNA interference is reversibly regulated by Cre recombinase 156
miR375-3p Distinguishes Low-Grade Neuroendocrine From Non-neuroendocrine Lung Tumors in FFPE Samples 156
Antisense RNA -induced exon-skipping for the gene therapy of Frontotemporal Dementia and Parkinsonism 154
Functional analysis of miRNAs involved in the regulation of the transcription factors Hoxa9, Hoxa10, Hoxa11 and Pax8 in epithelial ovarian cancer 154
Circulating miR-127-3p as a potential biomarker for differential diagnosis in frontotemporal dementia 153
MicroRNAs as lung cancer biomarkers 151
Upregulation of miR-133b and miR-328 in Patients With Atrial Dilatation: Implications for Stretch-Induced Atrial Fibrillation 150
Delivery of oligonucleotide-based therapeutics: challenges and opportunities 150
Antisense RNA-induced exon-skipping for the gene therapy of frontotemporal dementia and parkinsonism associated with chromosome 17 (ftdp-17) 148
Heterogeneity of Large Cell Carcinoma of the Lung: An Immunophenotypic and miRNA-Based Analysis. 147
71 nucleotides from the terminal right part of PSTVd is the sufficient minimum of RNA capable of sustaining specific binding to tomato protein Virp1 146
Long term benefit of AAV/antisense-mediated exon skipping in dystrophic mice 142
Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice 142
MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration 142
A vector for siRNA expression in mammalian cells that relies on polII-dependent transcription and produces asymmetric accumulation of one siRNA strand 139
Circulating microRNAs in Neurodegenerative Diseases 139
A study on the newt hammerhead ribozyme : association to RNA-binding proteins and intracellular localisation 138
A study on the newt hammerhead ribozyme : association to RNA-binding proteins and intracellular localisation 137
Antisense RNA -induced exon-skipping for the gene therapy of Frontotemporal Dementia and Parkinsonism 137
MicroRNA and Lung Cancer 137
Analisi della struttura e dell¿attivit¿ autocatalitica di trascritti dimerici ¿BglII¿ in Triturus 132
Measurements methods for the development of microRNA-based tests for cancer diagnosis 132
Circulating miRNAs as Biomarkers for Neurodegenerative Disorders 129
Fabry Disease: Antisense Therapeutics for intronic variations causing mis-spliced messenger RNA and active-site-specific chaperones (ASSC) for conformational enzyme defects 127
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model 124
Exon Skipping Through Chimeric Antisense U1 snRNAs to Correct Retinitis Pigmentosa GTPase-Regulator (RPGR) Splice Defect 124
Antisense RNA-mediated exon-skipping for gene therapy 122
Small RNA molecules of great utility as diagnostic biomarkers in lung cancer 122
mRNA fate: Life and death of the mRNA in the cytoplasm 121
Il ribozima di tritone: struttura ed applicazioni 119
New circuits between miRNAs and transcription factors Hoxa9, Hoxa10, Hoxa11 and Pax8: possible identification of therapeutic targets for epithelial ovarian cancer treatment 119
Short interfering RNAs specific for potato spindle tuber viroid are found in the cytoplasm but not in the nucleus 118
Circulating cell-free microRNAs as biomarkers for neurodegenerative diseases 117
Characterization of the RNA motif responsible for the specific interaction of potato spindle tuber viroid RNA (PSTVd) and the tomato protein Virp1 116
HCS-Splice: A High-Content Screening Method to Advance the Discovery of RNA Splicing-Modulating Therapeutics 115
PMP70 knock-down generates oxidative stress and pro-inflammatory cytokine production in C6 glial cells 114
Integrative microRNAome analysis of skeletal muscle of Colossoma macropomum (tambaqui), Piaractus mesopotamicus (pacu), and the hybrid tambacu, based on next-generation sequencing data 114
Replicating potato spindle tuber viroid RNA is accompanied by short RNA fragments that are characteristic of post-transcriptional gene silencing 113
AAV-mediated retinal gene transfer in animal models of retinal degeneration 108
The newt hammerhead ribozyme: structure and applications 108
Uso di un ribozima di vertebrati per l'inattivazione del gene MGMT in cellule CHO 107
RNAi-mediated silencing of ABCD3 gene expression in rat C6 glial cells: a model system to study PMP70 function 107
miR-92a-3p and miR-320a are Upregulated in Plasma Neuron-Derived Extracellular Vesicles of Patients with Frontotemporal Dementia 102
Uso di nuove proprietà dell' RNA per la terapia genica di infezioni da HIV = Use of new RNA properties for gene therapy of HIV infections 102
Characterization of the RNA motif responsible for the specific interaction of potato spindle tuber viroid RNA (PSTVd) and the tomato protein Virp1 102
Virp1 is a host protein with a major role in potato spindle tuber viroid infection in Nicotiana plants 102
Identification of miRNAs regulating MAPT expression and their analysis in plasma of patients with dementia 101
Preferential silencing of a common dominant rhodopsin mutation does not inhibit retinal degeneration in a transgenic model 100
Study on the affinity and specificity of the interaction between Potato Spindle Tuber viroid and tomato protein Virp1 99
Towards functional analysis of BVRB, a gene encoding for a viroid binding protein 98
La ribonucleoparticella del ribozima di tritone: fossile molecolare o una nuova particella coinvolta nel ¿processing¿ dell¿RNA? 98
Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study 97
News from around the RNA world: new avenues in RNA biology, biotechnology and therapeutics from the 2022 SIBBM meeting 97
MicroRNAs in epithelial ovarian cancer 97
SA-ODG platform: a semi-automated and PCR-free method to analyse microRNAs in solid tissues 93
Body-wide rescue of dystrophin and muscle function in mdx mice by antisense-snRNAs mediated exon-skipping 91
U1snRNA-mediated exon skipping for the therapy of Duchenne Muscular Dystrophy: towards a clinical trial 91
Characterisation of the protein components of the newt hammerhead ribozyme RNP 91
The motif in the Terminal Right Part of Potato Spindle Tuber Viroid is the determinant of specific in vitro recognition by tomato RNA-binding protein Virp1 90
Replicating viroid RNA is accompanied by short RNA fragments that are characteristic of posttranscriptional gene silencing 90
Identification of the RNA binding domain of Virp-1 90
Identification of miRNAs Bound to an RNA of Interest by MicroRNA Capture Affinity Technology (miR-CATCH) 90
Use of new RNA properties for gene therapy of HIV infections 89
Exon-skipping mediated by the systemic delivery of AAV constructs expressing antisense-snRNAs restores dystrophin and muscular functionality in body-wide skeletal muscles of mdx mice 89
Specificity of Potato Spindle Tuber Viroid RNA and viroid-binding protein (Virp1) interaction: A role of the auxiliary domains of Virp1 upon the RNA activity 89
Totale 14.220
Categoria #
all - tutte 66.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 1.294
selected - selezionate 0
volume - volumi 3.756
Totale 71.585


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022989 0 0 5 72 89 25 46 202 75 125 103 247
2022/20231.714 239 198 26 266 191 257 7 117 238 12 76 87
2023/2024658 48 53 38 24 67 153 44 56 6 59 32 78
2024/20252.603 15 29 128 508 121 341 44 178 286 491 203 259
2025/20265.248 437 110 647 779 555 459 919 146 422 429 228 117
2026/2027778 124 278 376 0 0 0 0 0 0 0 0 0
Totale 16.371